Stock listing
TPEx:6492 Senhwa Biosciences Inc (生華科) 股價
Follow Senhwa Biosciences Inc into a list and get an email when it puts out news.
Share price · TPEX:6492
$30.65 TWD -0.30 (-1.0%)
Close on Nov 2, 2026
- Day range
- $30.25 – $30.80 TWDNov 2, 2026
- Volume
- 122,689 sharesNov 2, 2026
- Market cap
- $3.51B TWDAt the close on Nov 2, 2026 · price × 114.4M shares outstanding
- 52-week range
- $30.25 – $66.50 TWDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $8.66M TWDMedian day 174,849 shares · 1 day with no trades · last 3 months, Aug 3, 2026 – Nov 2, 2026

Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · TPEX:6492 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $30.65 | -0.30 | -1.0% | $30.80 | $30.80 | $30.25 | 122,689 | |
| $30.95 | -0.80 | -2.5% | $31.55 | $31.55 | $30.25 | 323,382 | |
| $31.75 | -0.40 | -1.2% | $31.95 | $32.00 | $31.75 | 70,764 | |
| $32.15 | -0.10 | -0.3% | $31.95 | $32.15 | $31.70 | 75,570 | |
| $32.25 | -0.25 | -0.8% | $32.50 | $32.50 | $31.90 | 125,261 | |
| $32.50 | 0.00 | 0.0% | $32.50 | $32.50 | $32.50 | 0 | |
| $32.50 | -0.45 | -1.4% | $33.30 | $33.30 | $31.70 | 243,533 | |
| $32.95 | +0.20 | +0.6% | $33.45 | $33.45 | $32.70 | 124,782 | |
| $32.75 | -0.10 | -0.3% | $32.85 | $32.85 | $32.05 | 210,559 | |
| $32.85 | -0.70 | -2.1% | $33.70 | $33.70 | $32.30 | 268,033 | |
| $33.55 | +0.25 | +0.8% | $33.45 | $33.55 | $33.15 | 116,450 | |
| $33.30 | -0.80 | -2.3% | $33.90 | $33.90 | $33.00 | 236,555 | |
| $34.10 | +0.75 | +2.2% | $34.00 | $34.10 | $33.35 | 113,425 | |
| $33.35 | -0.65 | -1.9% | $34.00 | $34.00 | $33.25 | 220,001 | |
| $34.00 | +0.10 | +0.3% | $33.90 | $34.20 | $33.80 | 47,000 | |
| $33.90 | -0.10 | -0.3% | $34.20 | $34.20 | $33.90 | 83,488 | |
| $34.00 | +0.30 | +0.9% | $33.80 | $34.10 | $33.55 | 175,082 | |
| $33.70 | -0.15 | -0.4% | $34.30 | $34.30 | $33.70 | 99,468 | |
| $33.85 | -0.55 | -1.6% | $34.05 | $34.05 | $33.80 | 174,616 | |
| $34.40 | -0.20 | -0.6% | $34.90 | $34.90 | $34.00 | 123,005 | |
| $34.60 | +0.25 | +0.7% | $34.25 | $34.95 | $34.10 | 142,000 | |
| $34.35 | +0.20 | +0.6% | $34.35 | $34.40 | $34.05 | 191,200 | |
| $34.15 | -0.05 | -0.1% | $33.90 | $34.25 | $33.75 | 69,000 | |
| $34.20 | -0.20 | -0.6% | $34.40 | $34.40 | $33.80 | 123,095 | |
| $34.40 | +0.30 | +0.9% | $34.10 | $34.40 | $34.00 | 185,000 | |
| $34.10 | -0.10 | -0.3% | $34.40 | $34.50 | $33.85 | 112,160 | |
| $34.20 | +0.50 | +1.5% | $33.95 | $34.70 | $33.70 | 145,981 | |
| $33.70 | -0.65 | -1.9% | $34.30 | $34.45 | $33.70 | 200,207 | |
| $34.35 | +0.55 | +1.6% | $33.80 | $34.95 | $33.80 | 328,126 | |
| $33.80 | +0.50 | +1.5% | $33.45 | $33.80 | $33.25 | 92,100 | |
| $33.30 | -0.20 | -0.6% | $33.25 | $33.60 | $33.15 | 174,500 | |
| $33.50 | -0.10 | -0.3% | $33.80 | $34.00 | $33.50 | 153,003 | |
| $33.60 | -0.30 | -0.9% | $33.80 | $33.90 | $33.50 | 134,100 | |
| $33.90 | -0.10 | -0.3% | $34.10 | $34.25 | $33.70 | 168,845 | |
| $34.00 | -0.25 | -0.7% | $34.25 | $34.25 | $33.85 | 113,541 | |
| $34.25 | -0.10 | -0.3% | $34.20 | $34.35 | $33.65 | 238,615 | |
| $34.35 | +0.70 | +2.1% | $33.90 | $34.40 | $33.40 | 417,293 | |
| $33.65 | -0.15 | -0.4% | $33.80 | $34.15 | $33.35 | 287,809 | |
| $33.80 | -0.40 | -1.2% | $34.20 | $34.35 | $33.80 | 272,309 | |
| $34.20 | -0.15 | -0.4% | $34.25 | $34.30 | $34.05 | 160,235 | |
| $34.35 | -0.15 | -0.4% | $34.50 | $34.50 | $34.25 | 148,684 | |
| $34.50 | -0.45 | -1.3% | $34.95 | $34.95 | $34.05 | 369,328 | |
| $34.95 | -0.05 | -0.1% | $35.00 | $35.05 | $34.70 | 287,790 | |
| $35.00 | -0.70 | -2.0% | $35.70 | $35.80 | $34.65 | 585,788 | |
| $35.70 | +0.20 | +0.6% | $35.85 | $36.80 | $35.60 | 456,534 | |
| $35.50 | +0.85 | +2.5% | $35.00 | $35.75 | $34.70 | 497,862 | |
| $34.65 | -0.15 | -0.4% | $35.00 | $35.00 | $34.50 | 476,655 | |
| $34.80 | -2.90 | -7.7% | $33.95 | $35.00 | $33.95 | 2,122,024 | |
| $37.70 | +0.15 | +0.4% | $38.40 | $38.45 | $37.70 | 158,105 | |
| $37.55 | 0.00 | 0.0% | $37.55 | $38.50 | $37.55 | 134,100 | |
| $37.55 | -0.95 | -2.5% | $38.50 | $38.50 | $37.55 | 71,000 | |
| $38.50 | -0.30 | -0.8% | $38.80 | $38.80 | $38.10 | 103,225 | |
| $38.80 | +0.10 | +0.3% | $39.25 | $39.25 | $38.05 | 156,121 | |
| $38.70 | +0.85 | +2.2% | $37.85 | $39.65 | $37.85 | 355,224 | |
| $37.85 | -0.05 | -0.1% | $37.95 | $38.10 | $37.10 | 424,468 | |
| $37.90 | +0.45 | +1.2% | $37.20 | $37.95 | $37.20 | 228,301 | |
| $37.45 | -0.25 | -0.7% | $37.50 | $37.75 | $36.90 | 359,130 | |
| $37.70 | -1.00 | -2.6% | $38.70 | $38.70 | $37.00 | 538,812 | |
| $38.70 | -0.60 | -1.5% | $39.50 | $39.90 | $38.20 | 302,938 | |
| $39.30 | -1.80 | -4.4% | $40.30 | $40.30 | $39.25 | 271,200 | |
| $41.10 | +2.15 | +5.5% | $38.95 | $42.30 | $38.50 | 366,856 | |
| $38.95 | 0.00 | 0.0% | $38.60 | $38.95 | $38.50 | 189,061 |
- Ticker
- TPEx:6492
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TPEx
- Currency
- TWD
What changed lately
Latest news release · Aug 25, 2026
Senhwa Completes Enrollment in Phase 1b CX-5461 Expansion Trial; CSR Expected in Q1 2027
Latest news
Senhwa Completes Enrollment in Phase 1b CX-5461 Expansion Trial; CSR Expected in Q1 2027
Aug 25, 2026
Closed $35.50 (+2.5%) on Aug 25, 2026
Senhwa's CX-5461 Opens a New Frontier in Photoimmunotherapy; Multinational Study Published in Nucleic Acids Research
Aug 12, 2026
Closed $37.85 (-0.1%) on Aug 12, 2026
GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million
Jul 15, 2026
Closed $44.30 (+1.8%) on Jul 16, 2026
Senhwa Biosciences Launches Global Study, Targeting Breakthrough in Hard-to-Treat Cancers with CX-5461 and Tislelizumab Combination
May 5, 2026
Closed $50.70 (0.0%) on May 5, 2026
Senhwa Biosciences Secures Strategic Backing from Global Investor GEM with Up to NT$500 Million to Accelerate AI-Driven Drug Development
Apr 14, 2026
Closed $50.70 (-1.6%) on Apr 14, 2026
Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy
Mar 17, 2026
Closed $54.90 (+6.8%) on Mar 18, 2026
Senhwa Biosciences Signs Major Strategic MOU with Y Combinator-Backed AI Biotech Company CellType to Accelerate the Evolution of CX-4945 into Version 2.0 and Reshape the Global Immunotherapy Landscape
Mar 3, 2026
Closed $49.70 (-1.8%) on Mar 3, 2026
Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC "Blockbuster" Therapy
Dec 28, 2025
Closed $42.75 (+3.0%) on Dec 29, 2025
Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference
Dec 23, 2025
Closed $42.00 (-0.5%) on Dec 24, 2025
Senhwa Biosciences and BeOne Medicines Announces a Clinical Supply Agreement to Address the Challenge of Cold Tumors
Dec 10, 2025
Closed $41.55 (+3.0%) on Dec 11, 2025
Senhwa Biosciences Inc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 10 in the last 12 months · 21 in all · newest Aug 25, 2026 · oldest 2023
Log in to ask 6ix AI your own questions about Senhwa Biosciences Inc.